Miguel López de Rodas Gregorio, MD
Postdoctoral Associate
Research & Publications
Biography
Coauthors
Selected Publications
- Role of tumor infiltrating lymphocytes and spatial immune heterogeneity in sensitivity to PD-1 axis blockers in non-small cell lung cancerde Rodas M, Nagineni V, Ravi A, Datar IJ, Mino-Kenudson M, Corredor G, Barrera C, Behlman L, Rimm DL, Herbst RS, Madabhushi A, Riess JW, Velcheti V, Hellmann MD, Gainor J, Schalper KA. Role of tumor infiltrating lymphocytes and spatial immune heterogeneity in sensitivity to PD-1 axis blockers in non-small cell lung cancer. Journal For ImmunoTherapy Of Cancer 2022, 10: e004440. PMID: 35649657, PMCID: PMC9161072, DOI: 10.1136/jitc-2021-004440.
- Tumour antigen-induced T cell exhaustion — the archenemy of immune-hot malignanciesLopez de Rodas M, Schalper KA. Tumour antigen-induced T cell exhaustion — the archenemy of immune-hot malignancies. Nature Reviews Clinical Oncology 2021, 18: 749-750. PMID: 34556846, PMCID: PMC9235859, DOI: 10.1038/s41571-021-00562-5.
- Targeting the Atf7ip–Setdb1 Complex Augments Antitumor Immunity by Boosting Tumor ImmunogenicityHu H, Khodadadi-Jamayran A, Dolgalev I, Cho H, Badri S, Chiriboga LA, Zeck B, De Rodas Gregorio M, Dowling CM, Labbe K, Deng J, Chen T, Zhang H, Zappile P, Chen Z, Ueberheide B, Karatza A, Han H, Ranieri M, Tang S, Jour G, Osman I, Sucker A, Schadendorf D, Tsirigos A, Schalper KA, Velcheti V, Huang HY, Jin Y, Ji H, Poirier JT, Li F, Wong KK. Targeting the Atf7ip–Setdb1 Complex Augments Antitumor Immunity by Boosting Tumor Immunogenicity. Cancer Immunology Research 2021, 9: 1298-1315. PMID: 34462284, PMCID: PMC9414288, DOI: 10.1158/2326-6066.cir-21-0543.
- Functional transcriptomic annotation and protein-protein interaction analysis identify EZH2 and UBE2C as key upregulated proteins in ovarian cancer.Martínez-Canales S, López de Rodas M, Nuncia-Cantarero M, Páez R, Amir E, Győrffy B, Pandiella A, Galán-Moya EM, Ocaña A. Functional transcriptomic annotation and protein-protein interaction analysis identify EZH2 and UBE2C as key upregulated proteins in ovarian cancer. Cancer Medicine 2018, 7: 1896-1907. PMID: 29575713, PMCID: PMC5943485, DOI: 10.1002/cam4.1406.
- Transcriptomic immunologic signature associated with favorable clinical outcome in basal-like breast tumors.Martínez-Canales S, Cifuentes F, López De Rodas Gregorio M, Serrano-Oviedo L, Galán-Moya EM, Amir E, Pandiella A, Győrffy B, Ocaña A. Transcriptomic immunologic signature associated with favorable clinical outcome in basal-like breast tumors. PloS One 2017, 12: e0175128. PMID: 28472085, PMCID: PMC5417488, DOI: 10.1371/journal.pone.0175128.